TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
PBYI

Puma Biotechnology, Inc.

Healthcare · Biotechnology

9.50$ +1.4% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Puma Biotechnology, Inc. (PBYI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.8% of the shares are freely tradable; institutional investors hold 75.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 75.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 15.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 76.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 52Mio.

Largest Shareholders

Institutions

Institutions PBYI
Name Stake (%) Shares Change (%) Date
BlackRock Inc 6.97 3,598,952 -1.2 03/31/2026
American Century Companies Inc 4.49 2,319,996 +21.1 06/30/2026
Acadian Asset Management LLC 3.96 2,041,759 +711.3 03/31/2026
Renaissance Technologies Corp 3.76 1,942,413 -8.5 03/31/2026
Vanguard Capital Management, LLC 3.52 1,817,681 +0.0 03/31/2026
Vanguard Portfolio Management, LLC 3.36 1,734,649 +0.0 03/31/2026
LSV Asset Management 3.13 1,617,981 +36.8 06/30/2026
Dimensional Fund Advisors, Inc. 2.94 1,518,014 +5.7 06/30/2026

Funds

Funds PBYI
Name Stake (%) Shares Change (%) Date
Avantis US Small Cap Value ETF 4.38 2,262,093 +0.1 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.60 1,343,121 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings PBYI
Person Role Shares Value As of Type
Auerbach Alan H President and CEO 7,261,671 68,985,875 $ Jul 6, 2026 direct
Nougues Maximo F Chief Financial Officer 230,637 2,191,052 $ Jul 6, 2026 direct
Hunt Douglas M See Remarks 196,841 1,869,990 $ Jul 6, 2026 direct
Cesano Alessandra Director 56,700 538,650 $ Sep 14, 2026 direct
Wilson Troy Edward Director 54,750 520,125 $ Sep 14, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 14, 2026 Wilson Troy Edward Director Sell 5,000 9.10 45,500
Sep 14, 2026 Cesano Alessandra Director Sell 62,150 9.12 566,994
Sep 14, 2026 Cesano Alessandra Director Other 50,000 2.93 146,500
Jul 6, 2026 Auerbach Alan H President and CEO Sell 44,058 8.26 364,051
Jul 6, 2026 Hunt Douglas M See Remarks Sell 8,460 8.26 69,905
Jul 6, 2026 Nougues Maximo F Chief Financial Officer Sell 9,386 8.26 77,557

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?